Hypertension Complicating Cancer Chemotherapy

Handler, Joel

doi:10.1111/j.1524-6175.2006.05147.x

Cited by 2 publications

(2 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There have been concerns raised relating to possible increased blood pressure following bevacizumab intravitreal injections. This is a recognised complication of systemic bevacizumab,15 but so far this has not been a significant observation associated with intraocular use of the drug 8…”

Section: Discussionmentioning

confidence: 99%

Submacular haemorrhages after intravitreal bevacizumab for large occult choroidal neovascularisation in age-related macular degeneration

Goverdhan

Lochhead

2007

British Journal of Ophthalmology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Submacular haemorrhages after intravitreal bevacizumab for large occult choroidal neovascularisation in age-related macular degeneration

Goverdhan

Lochhead

2007

British Journal of Ophthalmology

View full text Add to dashboard Cite

show abstract

“…Cardiovascular disease is a leading preventable cause of morbidity and premature mortality in women 97 and can affect sexual function. Some chemotherapeutic regimens can cause transient or persistent elevation in blood pressure, 98,99 and cardiovascular changes resulting from menopause (natural or iatrogenic) can cause chronic blood pressure elevation. [100][101][102] Situational, or "whitecoat hypertension" is common in this patient population, especially when presenting for sexual concerns for the first time, and will present as mild to moderate elevation in systolic blood pressure with elevated pulse rate, typically in the range of 85 to 100 beats per minute.…”

Section: Vital Signsmentioning

confidence: 99%

Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialist

Lindau

Abramsohn

Baron

et al. 2016

CA A Cancer J Clinicians

View full text Add to dashboard Cite

Sexual concerns are prevalent in women with cancer or cancer history and are a factor in patient decision-making about cancer treatment and risk-reduction options. Physical examination of the female cancer patient with sexual concerns, regardless of the type or site of her cancer, is an essential and early component of a comprehensive evaluation and effective treatment plan. Specialized practices are emerging that focus specifically on evaluation and treatment of women with cancer and sexual function problems. As part of a specialized evaluation, oncologists and their patients should expect a thorough physical examination to identify or rule out physical causes of sexual problems or dysfunction. This review provides oncology professionals with a description of the physical examination of the female cancer patient with sexual function concerns. This description aims to inform anticipatory guidance for the patient and to assist in interpreting specialists’ findings and recommendations. In centers or regions where specialized care is not yet available, this review can also be used by oncology practices to educate and support health care providers interested in expanding their practices to treat women with cancer and sexual function concerns.

show abstract

Hypertension Complicating Cancer Chemotherapy

Cited by 2 publications

References 20 publications

Submacular haemorrhages after intravitreal bevacizumab for large occult choroidal neovascularisation in age-related macular degeneration

Submacular haemorrhages after intravitreal bevacizumab for large occult choroidal neovascularisation in age-related macular degeneration

Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialist

Contact Info

Product

Resources

About